PROLONG (PRostateOLaparibONcombinationGcc) Study

Clinical trial NCT07674121 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07674121
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Start date: 2026-06-30
Primary completion: 2029-09-30
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.